Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Lowers Price Target to $113
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $115 to $113.
August 08, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $115 to $113.
The lowered price target from $115 to $113 by Evercore ISI Group suggests a slightly negative outlook on Zimmer Biomet Holdings' stock performance. This could lead to a short-term decline in the stock price as investors react to the revised target.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100